IDAC THERANOSTICS
IDAC Theranostics is a Biotechnology Company and drug creation and R & D for diseases that only require coping therapy.
IDAC THERANOSTICS
Industry:
Biotechnology Therapeutics
Founded:
2012-04-02
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.idac-thera.com
Total Employee:
11+
Status:
Active
Contact:
03-3830-0816
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Sitelinks Search Box Euro Organization Schema Yoast WordPress SEO Plugin
Similar Organizations
Asgard Therapeutics
Asgard Therapeutics is a Biotechnology Company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Current Employees Featured
Investors List
Keio Innovation Initiative
Keio Innovation Initiative investment in Venture Round - IDAC Theranostics
Official Site Inspections
http://www.idac-thera.com
- Host name: idac-thera.com
- IP address: 122.28.35.79
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "IDAC Theranostics"
IDACセラノスティクス株式会社
IDACセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と …See details»
Company Outline - IDAC Theranostics
Idacセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と試薬を提供し、皆様の健康と健や …See details»
会社概要 - IDACセラノスティクス株式会社
IDACセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と試薬を提供し、皆様の健康と健や …See details»
IDAC Theranostics - Crunchbase Company Profile
Organization. IDAC Theranostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contact Email info …See details»
IDAC Theranostics - Our aim is to create innovative medicines
Idacセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と試薬を提供し、皆様の健康と健や …See details»
IDAC Theranostics, Inc.
[email protected] . 当社株式に関しまして 当社は株券不発行会社であり、また定款では株式に譲渡制限を付しております。 名義の書き換えは、当社取締役会の承認を得た場合に限り実施が可能となります。See details»
IDAC THERANOSTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IDAC THERANOSTICS, INC. of MACHIDA, TOKYO. Get the latest business insights from Dun & …See details»
IDAC Theranostics - PitchBook
IDAC Theranostics General Information Description. Developer of drug therapies designed for diseases for which there is only symptomatic treatment. The company collaborates with …See details»
IDAC Theranostics Company Profile - Office Locations ... - Craft
IDAC Theranostics (IDACセラノスティクス) is a biotech company that specializes in discovering and developing medicines. It targets inflammatory diseases and cancer, focusing on antibody …See details»
IDAC Theranostics
New information 2015.7.6 「Publication on anti-CD4 treatment againnst solid tumour」 The details are here. 2016.5.17 「Option agreement relating to anti-CD4 antibodySee details»
IDACセラノスティクス株式会社の会社情報と資金調達 | NIKKEI …
【NIKKEI COMPASS】IDACセラノスティクス株式会社は、対処療法しかない疾患を対象に医薬品の創造・研究開発に取り組む企業。大学発のバイオ ...See details»
Dosimetry for Radiopharmaceutical Therapy: Current Practices and ...
Dec 1, 2021 QDOSE uses the IDAC-Dose program (which includes 27 commonly used radionuclides) to calculate the mean normal-organ absorbed doses as the sum of the self …See details»
First-in-human phase 1 study of IT1208, a defucosylated …
IT1208 (IDAC Theranostics, Inc., Tokyo, Japan US8399621) is a humanized anti-CD4 immunoglobulin G1 mAb with a defucosylated Fc region, which markedly enhances antibody …See details»
IDAC Theranostics, Inc.
Management Philosophy： IDAC stands for "I"nflammatory "D"iseases "A"nd "C"ancer, and called “Ai-Dakku”. The word of “theranostics” is the neologism introduced by the ex-Chief Secretary …See details»
Combined treatment with HMGN1 and anti-CD4 depleting …
↵ d shoji.yokochi{at}idac-thera.com; ... telomere maintenance- and chromosome organization processes-related genes (Additional file 1:Figure S7). ... SU has ownership interest (including …See details»
Intermediate-dose cytarabine or standard-dose cytarabine plus …
Nov 13, 2021 For patients over 60, there is no consensus about such a strategy, and ELN recommendations suggest intermediate-dose cytarabine (IDAC) for 2–3 cycles in favorable …See details»
パイプライン - IDACセラノスティクス株式会社
IDACセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と試薬を提供し、皆様の健康と健や …See details»
IDAC Theranostics, Inc.
Business Pipeline. We would like to introduce our pipeline. Pipeline Our pipeline is as follows: (i) At first, we nominate humanized anti-CD4 mAb with potelligent® technology [NOTE] …See details»
抗CD4抗体 - IDACセラノスティクス株式会社
IDACセラノスティクス株式会社のオフィシャルサイト。事業パイプライン・会社概要等を掲載しています。私たちは高品質でニーズにマッチした医薬品と試薬を提供し、皆様の健康と健や …See details»